Kamada (KMDA) director files Form 3 detailing multiple option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Kamada Ltd director Karnit Goldwasser filed an initial Form 3 reporting holdings of stock options on Ordinary Shares. The filing lists several option grants with exercise prices of 7.5200 and 6.1500 per share, expiring between September 25, 2026 and June 22, 2029. Each grant covers either 6,625 or 7,500 underlying Ordinary Shares and is held directly. The options are exercisable using a net-exercise method, and the exercise prices in U.S. dollars reflect a convenience translation from NIS based on the Bank of Israel exchange rate as of March 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Goldwasser Karnit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to purchase Ordinary Shares — 6,625 shares (Direct)
Footnotes (1)
- These options to purchase ordinary shares are exercisable using a net-exercise method All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.
FAQ
What does the Kamada (KMDA) Form 3 filing by Karnit Goldwasser report?
The Form 3 reports Karnit Goldwasser’s initial holdings of stock options on Kamada Ordinary Shares. It lists multiple option grants with specified exercise prices, expiration dates, and underlying share amounts, establishing her baseline equity position as a director at the reporting date.
What stock option grants are disclosed for Kamada (KMDA) director Karnit Goldwasser?
The filing discloses several grants of options to purchase Kamada Ordinary Shares, each covering either 6,625 or 7,500 underlying shares. The options have exercise prices of 7.5200 or 6.1500 per share and expiration dates ranging from September 25, 2026 to June 22, 2029.
How are the exercise prices presented in the Kamada (KMDA) Form 3?
Exercise prices are shown in U.S. dollars as a convenience translation from NIS. A footnote explains they are based on the Bank of Israel representative exchange rate as of March 13, 2026, giving investors a clear dollar-based view of the option strike levels.
What exercise method applies to Karnit Goldwasser’s Kamada (KMDA) stock options?
A footnote states that the options to purchase Kamada Ordinary Shares are exercisable using a net-exercise method. This means, upon exercise, only the net shares after covering the exercise cost are issued, affecting the number of new shares actually delivered.
Are the options in the Kamada (KMDA) Form 3 held directly or indirectly?
The Form 3 indicates the options are held directly by Karnit Goldwasser. The ownership code is shown as direct, with no nature-of-ownership footnote describing any trust, partnership, or other indirect holding structure for these specific derivative positions.